Secreted protein acidic and rich in cysteine (SPARC) gene polymorphism association with hepatocellular carcinoma in Italian patients

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 12, 2009, Pages 1840-1846

  Segat, Ludovica ^a   Milanese, Michele ^a   Pirulli, Doroti ^a   Trevisiol, Chiara ^b   Lupo, Francesco ^c   Salizzoni, Mauro ^c   Amoroso, Antonio ^d   Crovella, Sergio ^a,e  

^a UNIVERSITY OF TRIESTE   (Italy)

^b San Polo Hospital   (Italy)

^c Liver Transplant Center AO S Giovanni Battista

^d UNIVERSITY OF TURIN   (Italy)

^e FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Hepatocarcinoma; Secreted protein acidic and rich in cysteine gene; Single nucleotide polymorphism

Indexed keywords

FLUORESCENT DYE; OSTEONECTIN;

ADULT; ALLELE; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE; GENE FUNCTION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; ITALY; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 72149105647     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.06009.x     Document Type: Article

References (37)

1. Teufel A, Staib F, Kanzler S et al. Genetics of hepatocellular carcinoma. World J. Gastroenterol. 2007 13 : 2271 2282.
2. McGlynn KA, Tsao L, Hsing AW, Devesa SS, Fraumeni JF Jr. International trends and patterns of primary liver cancer. Int. J. Cancer 2001 94 : 290 296.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: GLOBOCAN 2000. Int. J. Cancer 2001 94 : 153 156. (Pubitemid 32911406)
4. Capocaccia R, Sant M, Berrino F, Simonetti A, Santi V, Trevisani F. EUROCARE Working Group. Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am. J. Gastroenterol. 2007 102 (8 1661 1670 quiz 1660, 1671.
5. Anthony PP. Hepatocellular carcinoma: an overview. Histopathology 2001 39 : 109 118.
6. Tarao K, Rino Y, Takemiya S et al. Association between high serum alanine aminotransferase levels and more rapid development and higher rate of incidence of hepatocellular carcinoma in patients with hepatitis C virus-associated cirrhosis. Cancer 1999 86 : 589 595.
7. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995 21 : 650 655.
8. Yoshida H, Hamada T, Inuzuka S, Ueno T, Sata M, Tanikawa K. Bacterial infection in cirrhosis, with and without hepatocellular carcinoma. Am. J. Gastroenterol. 1993 88 : 2067 2071.
9. Buendia MA. Genetics of hepatocellular carcinoma. Semin. Cancer Biol. 2000 10 : 185 200.
10. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 2002 31 : 339 346.
11. Iizuka N, Oka M, Yamada-Okabe H et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res. 2002 62 : 3939 3944.
12. Stücker I, Loriot MA, N'koutchou G et al. UDP- glucuronosyltransferase UGT1A7 genetic polymorphisms in hepatocellular carcinoma: a differential impact according to seropositivity of HBV or HCV markers? BMC Cancer 2007 7 : 214.
13. Okabe H, Satoh S, Kato T et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res. 2001 61 (5 2129 2137.
14. Okabe H, Ikai I, Matsuo K et al. Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors. Hepatology 2000 31 (5 1073 1079.
15. Macarthur M, Hold GL, El-Omar EM. Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol. Gastrointest. Liver Physiol. 2004 286 : G515 520.
16. Edamoto Y, Hara A, Biernat W et al. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis. Int. J. Cancer 2003 106 : 334 341.
17. Karin M, Lawrence T, Nizet V. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 2006 124 : 823 835.
18. Chang JJ, Lewin SR. Immunopathogenesis of hepatitis B virus infection. Immunol. Cell Biol. 2007 85 : 16 23.
19. Szabo G, Dolganiuc A. HCV immunopathogenesis: virus-induced strategies against host immunity. Clin. Liver Dis. 2006 10 : 753 771.
20. Saito T, Ji G, Shinzawa H et al. Genetic variations in humans associated with differences in the course of hepatitis C. Biochem. Biophys. Res. Commun. 2004 317 : 335 341.
21. Kim YJ, Lee HS. Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection. Intervirology 2005 48 (1 10 15.
22. Jonsson JR, Purdie DM, Clouston AD, Powell EE. Recognition of genetic factors influencing the progression of hepatitis C: potential for personalized therapy. Mol. Diagn. Ther. 2008 12 : 209 218.
23. de Andrade DR Jr., de Andrade DR. The influence of the human genome on chronic viral hepatitis outcome. Rev. Inst. Med. Trop. Sao Paulo 2004 46 (3 119 126.
24. Lee WC, Wang LY. Simple formulas for gauging the potential impacts of population stratification bias. Am. J. Epidemiol. 2008 167 : 86 9.
25. Bosetti C, Bianchi C, Negri E, Colombo M, La Vecchia C. Estimates of the incidence and prevalence of hepatocellular carcinoma in Italy in 2002 and projections for the years 2007 and 2012. Tumori 2009 95 (1 23 7.
26. Midorikawa Y, Makuuchi M, Tang W, Aburatani H. Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges. World J. Gastroenterol. 2007 13 : 1487 1492.
27. Nishida N, Nishimura T, Ito T, Komeda T, Fukuda Y, Nakao K. Chromosomal instability and human hepatocarcinogenesis. Histol. Histopathol. 2003 Jul 18 (3 897 909.
28. Moinzadeh P, Breuhahn K, Stutzer H, Schirmacher P. Chromosome alterations in human hepatocellular carcinomas correlate with aetiology and histological grade - results of an explorative CGH meta-analysis. Br. J. Cancer 2005 92 : 935 941.
29. Feitelson MA. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Lett. 2006 239 (1 10 20.
30. Said N, Najwer I, Motamed K. Secreted protein acidic and rich in cysteine (SPARC) inhibits integrin-mediated adhesion and growth factor-dependent survival signaling in ovarian cancer. Am. J. Pathol. 2007 170 : 1054 1063.
31. McClung HM, Thomas SL, Osenkowski P et al. SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells. Neurosci. Lett. 2007 419 : 172 177.
32. Nakatani K, Seki S, Kawada N et al. Expression of SPARC by activated hepatic stellate cells and its correlation with the stages of fibrogenesis in human chronic hepatitis. Virchows Arch. 2002 441 : 466 474.
33. Lau CP, Poon RT, Cheung ST, Yu WC, Fan ST. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma. J. Pathol. 2006 210 : 459 468.
34. Aouacheria A, Navratil V, López-Pérez R et al. In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions. BMC Genomics 2007 8 : 2.
35. Khlat M, Cazes MH, Génin E, Guiguet M. Robustness of case-control studies of genetic factors to population stratification: magnitude of bias and type I error. Cancer Epidemiol. Biomarkers Prev. 2004 13 : 1660 1664.
36. Ardlie KG, Lunetta KL, Seielstad M. Testing for population subdivision and association in four case-control studies. Am. J. Hum. Genet. 2002 71 : 304 311.
37. Pritchard JK, Donnelly P. Case-control studies of association in structured or admixed populations. Theor. Popul. Biol. 2001 60 : 227 223.